Drug intelligence / Profile preview

triple viral + varicella vaccine-Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Development stage
Unknown
Lead developer
IDIAPJGOL
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intramuscular
01

Overview

The triple viral + varicella vaccine-Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina refers to the combination of the trivalent measles, mumps, and rubella (MMR) vaccine with the varicella (chickenpox) vaccine as utilized in clinical research by the Jordi Gol i Gurina Primary Care Research Institute (IDIAPJGol). This combination, often administered as a single quadrivalent injection (MMRV) or as co-administered separate injections, is a live-attenuated viral vaccine designed to induce active immunity against four major pediatric viral diseases. In the specific context of the IDIAPJGol study, this vaccine combination serves as a procedural stimulus to evaluate the efficacy of virtual reality (VR) as a non-pharmacological intervention for reducing pain and anxiety in children during routine immunization. The vaccine works by introducing weakened forms of the Measles morbillivirus, Mumps orthorubulavirus, Rubella virus, and Human alphaherpesvirus 3, thereby stimulating the production of specific antibodies and memory cells to prevent future infection.

Other names
triple viral + varicella vaccineMMRV vaccinemeasles, mumps, rubella and varicella vaccinetriple viral y varicela
02

Targets

VZV (Varicella-zoster virus)

Beyond the preview

Go deeper on triple viral + varicella vaccine-Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on triple viral + varicella vaccine-Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call